Investor List:

Top Pharmaceuticals Series A Investors in New York City (130)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Pharmaceuticals investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of David Bonita, General Partner at OrbiMed
David Bonita
OrbiMed·General Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Photo of Jonathan Rosenbaum, Managing Director at Insight Partners
Jonathan Rosenbaum
Insight Partners·Managing Director
Sweet spot: $25.0M
Range: $10.0M - $350.0M
Investors in New York (NY)
Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in Education (Seed), Investors in AI (Seed), Investors in SaaS (Seed), Investors in FinTech (Seed), Investors in Education (Seed), Investors in Enterprise (Seed), Investors in AI (Seed), Investors in FinTech (Seed), Investors in SaaS (Seed), Investors in Enterprise (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Education (Series A), Investors in AI (Series A), Investors in FinTech (Series A), Investors in SaaS (Series A), Investors in Education (Series A), Investors in Enterprise (Series A), Investors in FinTech (Series A), Investors in AI (Series A), Investors in SaaS (Series A), Investors in Enterprise (Series A), Investors in Pharmaceuticals (Series B), Investors in Education (Series B), Investors in Pharmaceuticals (Series B), Investors in AI (Series B), Investors in Education (Series B), Investors in FinTech (Series B), Investors in SaaS (Series B), Investors in Enterprise (Series B), Investors in AI (Series B), Investors in SaaS (Series B), Investors in FinTech (Series B), Investors in Enterprise (Series B), Investors in New York City (Other Lists)
Photo of Jared Newman, Investor at Canaan Partners
Jared Newman
Canaan Partners·Investor
Sweet spot: $10.0M
Range: $250K - $20.0M
Investors in New York City
Photo of Michael Aberman, Partner at SOSV
Michael Aberman
SOSV·Partner
Sweet spot: $1M
Range: $100K - $2.0M
Investors in New York (NY)
Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in New York City (Other Lists)
Photo of Sara Nayeem, Partner at Avoro Ventures
Sara Nayeem
Sweet spot: $1M
Range: $100K - $10.0M
Investors in New York City, Investors in Washington (DC)
Photo of Justine Potemkin, Investor at New Enterprise Associates (NEA)
Justine Potemkin
Sweet spot: $25.0M
Range: $2.0M - $50.0M
Investors in New York City
Photo of Sven Borho, Managing Partner at OrbiMed
Sven Borho
OrbiMed·Managing Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)
Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in New York City (Other Lists)
Photo of W. Carter Neild, Managing Partner at OrbiMed
W. Carter Neild
OrbiMed·Managing Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY)